Annual Drug Patent Expirations for JAYPIRCA
Jaypirca is a drug marketed by Loxo Oncol and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has sixty-two patent family members in thirty-four countries.
The generic ingredient in JAYPIRCA is pirtobrutinib. One supplier is listed for this compound. Additional details are available on the pirtobrutinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
